Adams R, Hunt M, Clark J. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. J Am Chem Soc. 1940;62:196–200.
CAS
Google Scholar
Alhamoruni A, Lee A, Wright K, Larvin M, O'sullivan S. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. J Pharmacol Exp Ther. 2010;335(1):92–102.
CAS
PubMed
Google Scholar
Alhamoruni A, Wright K, Larvin M, O'sullivan S. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Br J Pharmacol. 2012;165(8):2598–610.
CAS
PubMed
PubMed Central
Google Scholar
Alvarez F, Lafuente H, Rey-Santano C, et al. Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets. Pediatr Res. 2008;64(6):653–8.
CAS
PubMed
Google Scholar
Appendino G, Gibbons S, Giana A, et al. Antibacterial cannabinoids from Cannabis sativa: a structure− activity study. J Nat Prod. 2008;71(8):1427–30.
CAS
PubMed
Google Scholar
Arkell TR, Lintzeris N, Kevin RC, et al. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology. 2019;236(9):2713–24.
CAS
PubMed
PubMed Central
Google Scholar
Armstrong R, Warren G, Warren J. Mechanisms of exercise-induced muscle fibre injury. Sports Med. 1991;12(3):184–207.
CAS
PubMed
Google Scholar
Arndt D, de Wit H. Cannabidiol does not dampen responses to emotional stimuli in healthy adults. Cannabis Cannabinoid Res. 2017;2(1):105–13.
CAS
PubMed
PubMed Central
Google Scholar
Arnold J, Allsop D, Lintzeris N, Mcgregor I. Pharmacological actions and associated therapeutic levels of phytocannabinoids: an evidence Check review brokered by the Sax Institute (www.saxinstitute.org.au) for the NSW Ministry of Health. 2016.
Arruza L, Pazos M, Mohammed N, et al. Cannabidiol reduces lung injury induced by hypoxic–ischemic brain damage in newborn piglets. Pediatr Res. 2017;82(1):79–86.
CAS
PubMed
Google Scholar
Bakas T, van Nieuwenhuijzen PS, Devenish SO, McGregor IS, Arnold JC, Chebib M. The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors. Pharmacol Res. 2017;119:358–70.
CAS
PubMed
Google Scholar
Banister SD, Arnold JC, Connor M, Glass M, McGregor IS. Dark classics in chemical neuroscience: delta(9)-tetrahydrocannabinol. ACS Chem Neurosci. 2019;10(5):2160–75.
CAS
PubMed
Google Scholar
Barata L, Arruza L, Rodríguez M, et al. Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage. Neuropharmacology. 2019;146:1–11.
CAS
PubMed
Google Scholar
Belardo C, Iannotta M, Boccella S, et al. Oral cannabidiol prevents allodynia and neurological dysfunctions in a mouse model of mild traumatic brain injury. Front Pharmacol. 2019;10(352).
Bergamaschi M, Queiroz R, Chagas M, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219–26.
CAS
PubMed
PubMed Central
Google Scholar
Bergamaschi M, Queiroz R, Zuardi A, Crippa J. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011;6(4):237–49.
CAS
PubMed
Google Scholar
Bhattacharyya S, Fusar-Poli P, Borgwardt S, et al. Modulation of mediotemporal and ventrostriatal function in humans by Δ9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry. 2009;66(4):442–51.
CAS
PubMed
Google Scholar
Bhattacharyya S, Morrison P, Fusar-Poli P, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35(3):764–74.
CAS
PubMed
Google Scholar
Birnbaum A, Karanam A, Marino S, et al. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. Epilepsia. In Press.
Bonn-Miller M, Loflin M, Thomas B, Marcu J, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. J Am Med Assoc. 2017;318(17):1708–9.
Google Scholar
Booz G. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med. 2011;51(5):1054–61.
CAS
PubMed
PubMed Central
Google Scholar
Borgwardt S, Allen P, Bhattacharyya S, et al. Neural basis of Δ-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry. 2008;64(11):966–73.
CAS
PubMed
Google Scholar
Borrelli F, Aviello G, Romano B, et al. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med. 2009;87(11):1111–21.
CAS
PubMed
Google Scholar
Burstein S. Cannabidiol (CBD) and its analogs: A review of their effects on inflammation. Bioorg Med Chem. 2015;23(7):1377–85.
CAS
PubMed
Google Scholar
Campos A, Fogaça M, Sonego A, Guimarães F. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 2016;112:119–27.
CAS
PubMed
Google Scholar
Carlini E, Cunha J. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21(S1):417S–27S.
CAS
PubMed
Google Scholar
Carlini E, Leite J, Tannhauser M, Berardi A. Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents. J Pharm Pharmacol. 1973;25(8):664–5.
CAS
PubMed
Google Scholar
Carvalho RK, Santos ML, Souza MR, et al. Chronic exposure to cannabidiol induces reproductive toxicity in male Swiss mice (vol 38, pg 1215, 2018). J Appl Toxicol. 2018;38(12):1545.
CAS
PubMed
Google Scholar
Casey S, Atwal N, Vaughan C. Cannabis constituent synergy in a mouse neuropathic pain model. Pain. 2017;158(12):2452–60.
CAS
PubMed
Google Scholar
Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. 2002.
Google Scholar
Ceprián M, Jiménez-Sánchez L, Vargas C, Barata L, Hind W, Martínez-Orgado J. Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke. Neuropharmacology. 2017;116:151–9.
PubMed
Google Scholar
Chagas M, Eckeli A, Zuardi A, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series. J Clin Pharm Ther. 2014;39(5):564–6.
CAS
PubMed
Google Scholar
Chang Y, Windish D. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76–8.
PubMed
PubMed Central
Google Scholar
Cheng D, Low JK, Logge W, Garner B, Karl T. Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice. Psychopharmacology. 2014;231(15):3009–17.
CAS
PubMed
Google Scholar
Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice. J Alzheimers Dis. 2014;42(4):1383–96.
CAS
PubMed
Google Scholar
Clarkson P, Nosaka K, Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc. 1992;24(5):512–20.
CAS
PubMed
Google Scholar
Consroe P, Kennedy K, Schram K. Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans. Pharmacol Biochem Behav. 1991;40(3):517–22.
CAS
PubMed
Google Scholar
Cosimo R. The effects of exercise on bone: basic concepts and implications for the prevention of fractures. Clin Cases Miner Bone Metab. 2009;6(3):223.
Google Scholar
Costa B, Colleoni M, Conti S, et al. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of Cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedeberg's Arch Pharmacol. 2004;369(3):294–9.
CAS
Google Scholar
Costa B, Giagnoni G, Franke C, Trovato A, Colleoni M. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. Br J Pharmacol. 2004;143(2):247–50.
CAS
PubMed
Google Scholar
Costa B, Trovato A, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007;556(1-3):75–83.
CAS
PubMed
Google Scholar
Costa B, Vailati S, Colleoni M. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats. Behav Pharmacol. 1999;10(3):327–31.
CAS
PubMed
Google Scholar
Craft L, Magyar M, Becker B, Feltz D. The relationship between the Competitive State Anxiety Inventory-2 and sport performance: A meta-analysis. J Sport Exerc Psychol. 2003;25(1):44–65.
Google Scholar
Crippa J, Derenusson G, Ferrari T, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011;25(1):121–30.
CAS
PubMed
Google Scholar
Crippa J, Zuardi A, Garrido G, et al. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29(2):417–26.
CAS
PubMed
Google Scholar
Cunha J, Carlini E, Pereira A, et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980;21(3):175–85.
CAS
PubMed
Google Scholar
da Silva V, de Freitas B, Dornelles V, et al. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol. Brain Res Bull. 2018;139:1–8.
PubMed
Google Scholar
da Silva V, de Freitas B, Garcia R, et al. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload. Transl Psychiatry. 2018;8(1):176.
PubMed
PubMed Central
Google Scholar
Dalton W, Martz R, Lemberger L, Rodda B, Forney R. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects. Clin Pharmacol Therapeut. 1976;19(3):300–9.
CAS
Google Scholar
De Filippis D, Esposito G, Cirillo C, et al. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 2011;6(12):e28159.
PubMed
PubMed Central
Google Scholar
De Gregorio D, McLaughlin R, Posa L, et al. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. 2019;160(1):136–50.
PubMed
Google Scholar
Deiana S, Watanabe A, Yamasaki Y, et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour. Psychopharmacology. 2012;219(3):859–73.
CAS
PubMed
Google Scholar
Devinsky O, Cross H, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the dravet syndrome. N Engl J Med. 2017;376(21):2011–20.
CAS
PubMed
Google Scholar
Devinsky O, Patel A, Cross H, et al. Effect of cannabidiol on drop seizures in the Lennox–Gastaut Syndrome. N Engl J Med. 2018;378(20):1888–97.
CAS
PubMed
Google Scholar
Durst R, Danenberg H, Gallily R, et al. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. Am J Phys Heart Circ Phys. 2007;293(6):H3602–7.
CAS
Google Scholar
El Sohly M, Radwan M, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. In: Phytocannabinoids: Springer; 2017. p. 1–36.
Elmes MW, Kaczocha M, Berger WT, et al. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). J Biol Chem 2015;290:8711–21.
CAS
PubMed
PubMed Central
Google Scholar
Farrimond J, Whalley B, Williams C. Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology. 2012;223(1):117–29.
CAS
PubMed
Google Scholar
Fatouros I, Jamurtas A. Insights into the molecular etiology of exercise-induced inflammation: opportunities for optimizing performance. J Inflamm Res. 2016;9:175–86.
PubMed
PubMed Central
Google Scholar
Feng Y, Chen F, Yin T, et al. Pharmacologic effects of cannabidiol on acute reperfused myocardial infarction in rabbits: Evaluated with 3.0 T cardiac magnetic resonance imaging and histopathology. J Cardiovasc Pharmacol. 2015;66(4):354–63.
CAS
PubMed
Google Scholar
Fike J. Industrial hemp: renewed opportunities for an ancient crop. Crit Rev Plant Sci. 2016;35(5-6):406–24.
Google Scholar
Fouad A, Al-Mulhim A, Jresat I. Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats. Life Sci. 2012;91(7-8):284–92.
CAS
PubMed
Google Scholar
Fouad A, Jresat I. Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats. Eur J Pharmacol. 2011;670(1):216–23.
CAS
PubMed
Google Scholar
Fralick M, Sy E, Hassan A, Burke M, Mostofsky E, Karsies T. Association of concussion with the risk of suicide: a systematic review and meta-analysis. JAMA Neurol. 2019;76(2):144–51.
PubMed
Google Scholar
Fride E, Ponde D, Breuer A, Hanuš L. Peripheral, but not central effects of cannabidiol derivatives: Mediation by CB1 and unidentified receptors. Neuropharmacology. 2005;48(8):1117–29.
CAS
PubMed
Google Scholar
Fujii Y, Ozaki N, Taguchi T, Mizumura K, Furukawa K, Sugiura Y. TRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle soreness. Pain. 2008;140(2):292–304.
CAS
PubMed
Google Scholar
Fusar-Poli P, Crippa J, Bhattacharyya S, et al. Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009;66(1):95–105.
CAS
PubMed
Google Scholar
Garberg H, Huun M, Escobar J, et al. Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets. Pediatr Res. 2016;80(5):710–8.
CAS
PubMed
Google Scholar
Garberg H, Solberg R, Barlinn J, Martinez-Orgado J, Løberg E, Saugstad O. High-dose cannabidiol induced hypotension after global hypoxia-ischemia in piglets. Neonatology. 2017;112(2):143–9.
CAS
PubMed
Google Scholar
Genaro K, Fabris D, Arantes A, Zuardi A, Crippa J, Prado W. Cannabidiol Is a potential therapeutic for the affective-motivational dimension of incision pain in rats. Front Pharmacol. 2017;8(391).
Gigli S, Seguella L, Pesce M, et al. Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells. United European Gastroenterol J. 2017;5(8):1108–15.
CAS
PubMed
PubMed Central
Google Scholar
Greco T, Ferguson L, Giza C, Prins M. Mechanisms underlying vulnerabilities after repeat mild traumatic brain injuries. Exp Neurol. 2019;317.
Green B, Kavanagh D, Young R. Being stoned: A review of self-reported cannabis effects. Drug Alcohol Rev. 2003;22(4):453–60.
PubMed
Google Scholar
Hainline B, Derman W, Vernec A, et al. International Olympic Committee consensus statement on pain management in elite athletes. Br J Sports Med. 2017;51(17):1245–58.
PubMed
Google Scholar
Hammell D, Zhang L, Ma F, et al. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 2016;20(6):936–48.
CAS
PubMed
Google Scholar
Hanuš L, Meyer S, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357–92.
PubMed
Google Scholar
Hao E, Mukhopadhyay P, Cao Z, et al. Cannabidiol Protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis. Mol Med. 2015;21:38–45.
CAS
PubMed
PubMed Central
Google Scholar
Harris H, Sufka K, Gul W, El Sohly M. Effects of delta-9-tetrahydrocannabinol and cannabidiol on cisplatin-induced neuropathy in mice. Planta Med. 2016;82(13):1169–72.
CAS
PubMed
Google Scholar
Hausswirth C, Louis J, Aubry A, Bonnet G, Duffield R. Y LEM. Evidence of disturbed sleep and increased illness in overreached endurance athletes. Med Sci Sports Exerc. 2014;46(5):1036–45.
PubMed
Google Scholar
Hayakawa K, Irie K, Sano K, et al. Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism. Biol Pharm Bull. 2009;32(9):1538–44.
CAS
PubMed
Google Scholar
Hayakawa K, Mishima K, Irie K, et al. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism. Neuropharmacology. 2008;55(8):1280–6.
CAS
PubMed
Google Scholar
Hayakawa K, Mishima K, Nozako M, et al. Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism. J Neurochem. 2007;102(5):1488–96.
CAS
PubMed
Google Scholar
Hayakawa K, Mishima K, Nozako M, et al. Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology. 2007;52(4):1079–87.
CAS
PubMed
Google Scholar
Hillard C. Circulating endocannabinoids: From whence do they come and where are they going? Neuropsychopharmacology. 2018;43(1):155–72.
CAS
PubMed
Google Scholar
Hiltunen A, Järbe T, Wängdahl K. Cannabinol and cannabidiol in combination: Temperature, open-field activity, and vocalization. Pharmacol Biochem Behav. 1988;30(3):675–8.
CAS
PubMed
Google Scholar
Hindocha C, Freeman T, Schafer G, et al. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. Eur Neuropsychopharmacol. 2015;25(3):325–34.
CAS
PubMed
PubMed Central
Google Scholar
Hoggart B, Ratcliffe S, Ehler E, et al. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain. J Neurol. 2015;262(1):27–40.
CAS
PubMed
Google Scholar
Hollister L. Actions of various marihuana derivatives in man. Pharmacol Rev. 1971;23(4):349–57.
CAS
PubMed
Google Scholar
Huestis M, Mazzoni I, Rabin O. Cannabis in sport: anti-doping perspective. Sports Med. 2011;41(11):949–66.
PubMed
PubMed Central
Google Scholar
Hundal H, Lister R, Evans N, et al. The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group. J Psychopharmacol. 2017;32(3):276–82.
PubMed
Google Scholar
Iannotti F, Pagano E, Moriello A, et al. Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic MDX mice. Br J Pharmacol. 2019;176(10):1568–84.
CAS
PubMed
Google Scholar
Ibeas Bih C, Chen T, Nunn A, Bazelot M, Dallas M, Whalley B. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics. 2015;12(4):699–730.
PubMed
PubMed Central
Google Scholar
Ignatowska-Jankowska B, Jankowski M, Swiergiel A. Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors. Neurosci Lett. 2011;490(1):82–4.
CAS
PubMed
Google Scholar
Irving P, Iqbal T, Nwokolo C, et al. A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflamm Bowel Dis. 2018;24(4):714–24.
PubMed
Google Scholar
Jadoon K, Tan G, O'Sullivan S. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight. 2017;2(12):e93760.
PubMed Central
Google Scholar
Javadi-Paydar M, Nguyen J, Kerr T, et al. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats. Psychopharmacology. 2018;235(9):2541–57.
CAS
PubMed
PubMed Central
Google Scholar
Kamins J, Giza C. Concussion—mild traumatic brain injury: Recoverable injury with potential for serious sequelae. Neurosurg Clin. 2016;27(4):441–52.
Google Scholar
Karniol I, Shirakawa I, Kasinski N, Pfeferman A, Carlini E. Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man. Eur J Pharmacol. 1974;28(1):172–7.
CAS
PubMed
Google Scholar
Kennedy M. Cannabis: Exercise performance and sport. A systematic review. J Sci Med Sport. 2017;20(9):825–9.
PubMed
Google Scholar
Khaksar S, Bigdeli M. Correlation between cannabidiol-induced reduction of infarct volume and inflammatory factors expression in ischemic stroke model. Basic Clin Neurosci. 2017;8(2):139–46.
CAS
PubMed
PubMed Central
Google Scholar
King K, Myers A, Soroka-Monzo A, et al. Single and combined effects of Δ9-tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain. Br J Pharmacol. 2017;174(17):2832–41.
CAS
PubMed
PubMed Central
Google Scholar
Klein M, de Quadros De Bortolli J, Guimarães F, Salum F, Cherubini K, de Figueiredo M. Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation. Phytother Res. 2018;32(11):2275–81.
CAS
PubMed
Google Scholar
Kogan N, Melamed E, Wasserman E, et al. Cannabidiol, a major non-psychotropic Cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts. J Bone Miner Res. 2015;30(10):1905–13.
CAS
PubMed
Google Scholar
Kraft B, Frickey N, Kaufmann R, et al. Lack of analgesia by oral standardized Cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology. 2008;109(1):101–10.
PubMed
Google Scholar
Lafuente H, Pazos M, Alvarez A, et al. Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia. Front Neurosci. 2016;10:323.
PubMed
PubMed Central
Google Scholar
Laprairie R, Bagher A, Kelly M, Denovan-Wright E. Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor. Br J Pharmacol. 2015;172(20):4790–805.
CAS
PubMed
PubMed Central
Google Scholar
Lattanzi S, Brigo F, Trinka E, et al. Efficacy and safety of cannabidiol in epilepsy: A systematic review and meta-analysis. Drugs. 2018;78(17):1791–804.
CAS
PubMed
Google Scholar
Leas EC, Nobles AL, Caputi TL, Dredze M, Smith DM, Ayers JW. Trends in Internet searches for cannabidiol (CBD) in the United States. JAMA Netw Open. 2019;2(10):–e1913853.
Leeder J, Glaister M, Pizzoferro K, Dawson J, Pedlar C. Sleep duration and quality in elite athletes measured using wristwatch actigraphy. J Sports Sci. 2012;30(6):541–5.
PubMed
Google Scholar
Leweke F, Piomelli D, Pahlisch F, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012;2:e94.
CAS
PubMed
PubMed Central
Google Scholar
Leweke M, Schneider U, Radwan M, Schmidt E, Emrich H. Different effects of nabilone and cannabidiol on binocular depth inversion in man. Pharmacol Biochem Behav. 2000;66(1):175–81.
CAS
PubMed
Google Scholar
Li D, Lin Z, Meng Q, Wang K, Wu J, Yan H. Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury. Eur J Pharmacol. 2017;809:13–9.
CAS
PubMed
Google Scholar
Li H, Kong W, Chambers C, et al. The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice. Cell Immunol. 2018;329:1–9.
CAS
PubMed
PubMed Central
Google Scholar
Lichtman A, Lux E, McQuade R, et al. Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain. J Pain Symptom Manag. 2018;55(2):179–88.
Google Scholar
Linares I, Guimaraes F, Eckeli A, et al. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: A randomized, double-blind, placebo-controlled, crossover study. Front Pharmacol. 2018;9:315.
PubMed
PubMed Central
Google Scholar
Linares I, Zuardi A, Pereira L, et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry. 2019;41(1):9–14.
PubMed
Google Scholar
Logue D, Madigan S, Delahunt E, Heinen M, Mc Donnell S, Corish C. Low energy availability in athletes: A review of prevalence, dietary patterns, physiological health, and sports performance. Sports Med. 2018;48(1):73–96.
PubMed
Google Scholar
Long L, Chesworth R, Huang X, McGregor I, Arnold J, Karl T. A behavioural comparison of acute and chronic Delta(9)-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Int J Neuropsychopharmacol. 2010;13(7):861–76.
CAS
PubMed
Google Scholar
Lowe HI, Toyang NJ, McLaughlin W. Potential of cannabidiol for the treatment of viral hepatitis. Pharm Res. 2017;9(1):116.
CAS
Google Scholar
Machida M, Takemasa T. Ibuprofen administration during endurance training cancels running-distance-dependent adaptations of skeletal muscle in mice. J Physiol Pharmacol. 2010;61(5):559–63.
CAS
PubMed
Google Scholar
Malhotra R. Sleep, recovery, and performance in sports. Neurol Clin. 2017;35(3):547–57.
PubMed
Google Scholar
Maor Y, Yu J, Kuzontkoski PM, Dezube BJ, Zhang X, Groopman JE. Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma–associated herpesvirus-infected endothelium. Genes Cancer. 2012;3(7-8):512–20.
PubMed
PubMed Central
Google Scholar
Martin-Santos R, Crippa J, Batalla A, et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des. 2012;18(32):4966–79.
CAS
PubMed
Google Scholar
Masataka N. Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders. Front Psychol. 2019;10:2466.
PubMed
PubMed Central
Google Scholar
McGregor I, Abelev S, Cohen R. et al, Access to Cannabidiol without a Prescription: A Cross-Country Comparison and Analysis. Int J Drug Policy. Under Review.
Merrick J, Lane B, Sebree T, Yaksh T, O'Neill C, Banks S. Identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid. Cannabis Cannabinoid Res. 2016;1(1):102–12.
CAS
PubMed
PubMed Central
Google Scholar
Mohammed N, Ceprian M, Jimenez L, Ruth Pazos M, Martínez-Orgado J. Neuroprotective effects of cannabidiol in hypoxic ischemic insult: The therapeutic window in newborn mice. CNS Neurol Dis Drug Targets. 2017;16(1):102–8.
CAS
Google Scholar
Monti J. Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology. 1977;55(3):263–5.
CAS
PubMed
Google Scholar
Mori M, Meyer E, Soares L, Milani H, Guimarães F, de Oliveira R. Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2017;75:94–105.
CAS
Google Scholar
Mukhopadhyay P, Rajesh M, Horváth B, et al. Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med. 2011;50(10):1368–81.
CAS
PubMed
PubMed Central
Google Scholar
Murillo-Rodriguez E, Désarnaud F, Prospéro-García O. Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci. 2006;79(1):30–7.
CAS
PubMed
Google Scholar
Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero M, Mechoulam R, Drucker-Colín R. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett. 2006;580(18):4337–45.
PubMed
Google Scholar
Naftali T, Mechulam R, Marii A, et al. Low-dose cannabidiol is safe but not effective in the treatment for Crohn’s disease: A randomized controlled trial. Dig Dis Sci. 2017;62(6):1615–20.
CAS
PubMed
Google Scholar
Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27–31.
PubMed
PubMed Central
Google Scholar
Napimoga M, Benatti B, Lima F, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol. 2009;9(2):216–22.
CAS
PubMed
Google Scholar
Nichols JM, Kaplan BL. Immune responses regulated by cannabidiol. Cannabis Cannabinoid Res. 2020;5(1):12–31.
PubMed
PubMed Central
Google Scholar
Nicholson A, Turner C, Stone B, Robson P. Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24(3):305–13.
CAS
PubMed
Google Scholar
Noreen N, Muhammad F, Akhtar B, Azam F, Anwar MI. Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications. Crit Rev Eukaryot Gene Expr. 2018;28(1):73–86.
PubMed
Google Scholar
O'Sullivan S, Sun Y, Bennett A, Randall M, Kendall D. Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol. 2009;612(1-3):61–8.
CAS
PubMed
Google Scholar
Ota H, Katanosaka K, Murase S, Kashio M, Tominaga M, Mizumura K. TRPV1 and TRPV4 play pivotal roles in delayed onset muscle soreness. PLoS One. 2013;8(6):e65751.
CAS
PubMed
PubMed Central
Google Scholar
Patel D, Omar H, Terry M. Sport-related performance anxiety in young female athletes. J Pediatr Adolesc Gynecol. 2010;23(6):325–35.
PubMed
Google Scholar
Pazos M, Cinquina V, Gómez A, et al. Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology. 2012;63(5):776–83.
CAS
PubMed
Google Scholar
Pazos R, Mohammed N, Lafuente H, et al. Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors. Neuropharmacology. 2013;71:282–91.
CAS
PubMed
Google Scholar
Peterson J, Trappe T, Mylona E, et al. Ibuprofen and acetaminophen: Effect on muscle inflammation after eccentric exercise. Med Sci Sports Exerc. 2003;35(6):892–6.
CAS
PubMed
Google Scholar
Philpott H, O’Brien M, McDougall J. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017;158(12):2442.
CAS
PubMed
PubMed Central
Google Scholar
Pichini S, Mannocchi G, Berretta P, et al. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of “Light Cannabis” Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use. Ther Drug Monit. 2020;42(1):151–6.
PubMed
Google Scholar
Pisanti S, Malfitano AM, Ciaglia E, et al. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacol Ther. 2017;175:133–50.
CAS
PubMed
Google Scholar
Poklis J, Mulder H, Peace M. The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids. Forensic Sci Int. 2019;294:e25–7.
CAS
PubMed
Google Scholar
Ribeiro A, Ferraz-de-Paula V, Pinheiro M, et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor. Eur J Pharmacol. 2012;678(1):78–85.
CAS
PubMed
Google Scholar
Rossi F, Tortora C, Punzo F, et al. The endocannabinoid/endovanilloid system in bone: From osteoporosis to osteosarcoma. Int J Mol Sci. 2019;20(8):1919.
CAS
PubMed Central
Google Scholar
Russo M, Naro A, Leo A, et al. Evaluating Sativex® in neuropathic pain management: A clinical and neurophysiological assessment in multiple sclerosis. Pain Med. 2016;17(6):1145–54.
PubMed
Google Scholar
Sargent C, Lastella M, Halson S, Roach G. The impact of training schedules on the sleep and fatigue of elite athletes. Chronobiol Int. 2014;31(10):1160–8.
PubMed
Google Scholar
Schiavon A, Soares L, Bonato J, Milani H, Guimaraes F, de Oliveira R. Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox Res. 2014;26(4):307–16.
CAS
PubMed
Google Scholar
Schicho R, Storr M. Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice. Pharmacology. 2012;89(3-4):149–55.
CAS
PubMed
PubMed Central
Google Scholar
Scopinho A, Guimarães F, Corrêa F, Resstel L. Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. Pharmacol Biochem Behav. 2011;98(2):268–72.
CAS
PubMed
Google Scholar
Serpell M, Ratcliffe S, Hovorka J, et al. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain. 2014;18(7):999–1012.
CAS
PubMed
Google Scholar
Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: A case report. Permanente J. 2016;20(4):108.
Google Scholar
Smith L. Acute inflammation: The underlying mechanism in delayed onset muscle soreness? Med Sci Sports Exerc. 1991;23(5):542–51.
CAS
PubMed
Google Scholar
Sofia D, Knobloch L. Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav. 1976;4(5):591–9.
CAS
PubMed
Google Scholar
Spindle TR, Cone EJ, Goffi E, et al. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend. 2020;107937.
Stanley C, Hind W, Tufarelli C, O'Sullivan S. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1activation. Cardiovasc Res. 2015;107(4):568–78.
CAS
PubMed
PubMed Central
Google Scholar
Stanley C, Wheal A, Randall M, O’Sullivan S. Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes. Eur J Pharmacol. 2013;720(1-3):376–82.
CAS
PubMed
Google Scholar
Stout S, Cimino N. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: A systematic review. Drug Metab Rev. 2014;46(1):86–95.
CAS
PubMed
Google Scholar
Sultan S, England T, O’Sullivan S. Acute and chronic effects of cannabidiol on haemodynamics in healthy males. Bethesda: 29th annual symposium of the International Cannabinoid Research Society; 2019.
Google Scholar
Sultan S, Millar S, England T, O'Sullivan S. A systematic review and meta-analysis of the haemodynamic effects of cannabidiol. Front Pharmacol. 2017;8:81.
PubMed
PubMed Central
Google Scholar
Taffe M, Creehan K, Vandewater S. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats. Br J Pharmacol. 2015;172(7):1783–91.
CAS
PubMed
PubMed Central
Google Scholar
Tagne A, Pacchetti B, Sodergren M, Cosentino M, Marino F. Cannabidiol for Viral Diseases: Hype or Hope? Cannabis Cannabinoid Res. In Press.
Taylor D, Fennessy M. Biphasic nature of the effects of Δ9-tetrahydrocannabinol on body temperature and brain amines of the rat. Eur J Pharmacol. 1977;46(2):93–9.
CAS
PubMed
Google Scholar
Taylor L, Crockett J, Tayo B, Morrison G. A phase 1, open-label, parallel-group, single-dose trial of the pharmacokinetics and safety of cannabidiol (CBD) in subjects with mild to severe hepatic impairment. J Clin Pharmacol. 2019;58(8):1110–9.
Google Scholar
Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32(11):1053–67.
CAS
PubMed
PubMed Central
Google Scholar
Tham M, Yilmaz O, Alaverdashvili M, Kelly MEM, Denovan-Wright EM, Laprairie RB. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br J Pharmacol. 2019;176(10):1455–69.
CAS
PubMed
Google Scholar
Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391(10125):1085–96.
CAS
PubMed
Google Scholar
Thomas D, Erdman K, Burke L. American College of Sports Medicine joint position Statement: Nutrition and athletic performance. Med Sci Sports Exerc. 2016;48(3):543–68.
CAS
PubMed
Google Scholar
Toth C, Jedrzejewski N, Ellis C, Frey W. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. Mol Pain. 2010;6(1):16.
PubMed
PubMed Central
Google Scholar
Trappe T, White F, Lambert C, Cesar D, Hellerstein M, Evans W. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab. 2002;282(3):E551–6.
CAS
PubMed
Google Scholar
Trinh K, Diep D, Robson H. Marijuana and Its effects on athletic performance: A systematic review. Clin J Sport Med. 2018;28(4):350–7.
PubMed
Google Scholar
Ujvary I, Hanus L. Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy. Cannabis Cannabinoid Res. 2016;1(1):90–101.
CAS
PubMed
PubMed Central
Google Scholar
Valvassori SS, Bavaresco DV, Scaini G, et al. Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain. Rev Bras Psiquiatr. 2013;35(4):380–6.
PubMed
Google Scholar
Van Klingeren B, Ten Ham M. Antibacterial activity of Δ 9-tetrahydrocannabinol and cannabidiol. Antonie Van Leeuwenhoek. 1976;42(1-2):9–12.
PubMed
Google Scholar
van Wijck K, Lenaerts K, Grootjans J, et al. Physiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: Strategies for evaluation and prevention. Am J Physiol Gastrointest Liver Physiol. 2012;303(2):G155–68.
PubMed
Google Scholar
Van Wijck K, Lenaerts K, Van Bijnen A, et al. Aggravation of exercise-induced intestinal injury by Ibuprofen in athletes. Med Sci Sports Exerc. 2012;44(12):2257–62.
PubMed
Google Scholar
Varvel S, Wiley J, Yang R, et al. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology. 2006;186(2):226–34.
CAS
PubMed
Google Scholar
Wachtel S, El Sohly M, Ross S, Ambre J, De Wit H. Comparison of the subjective effects of Δ 9-tetrahydrocannabinol and marijuana in humans. Psychopharmacology. 2002;161(4):331–9.
CAS
PubMed
Google Scholar
Walsh NP. Recommendations to maintain immune health in athletes. Eur J Sport Sci. 2018;18(6):820–31.
PubMed
Google Scholar
Walsh S, Hepburn C, Kane K, Wainwright C. Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. Br J Pharmacol. 2010;160(5):1234–42.
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Mukhopadhyay P, Cao Z, et al. Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep. 2017;7(1):12064.
PubMed
PubMed Central
Google Scholar
Ward S, McAllister S, Kawamura R, Murase R, Neelakantan H, Walker E. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy. Br J Pharmacol. 2014;171(3):636–45.
CAS
PubMed
PubMed Central
Google Scholar
Ware M, Jensen D, Barrette A, Vernec A, Derman W. Cannabis and the health and performance of the elite athlete. Clin J Sport Med. 2018;28(5):480–4.
PubMed
PubMed Central
Google Scholar
Watanabe K, Itokawa Y, Yamaori S, et al. Conversion of cannabidiol to Δ9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice. Forensic Toxicol. 2007;25(1):16–21.
CAS
Google Scholar
Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R, Gallily R. Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice. Neuropharmacology. 2008;54(1): 244–9.
CAS
PubMed
Google Scholar
Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavini S, & Gallily R. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006;39(2):143–51.
CAS
PubMed
Google Scholar
Wendt D, Van Loon L, Van Marken Lichtenbelt W. Thermoregulation during exercise in the heat. Sports Med. 2007;37(8):669–82.
PubMed
Google Scholar
Wheal A, Cipriano M, Fowler C, Randall M, O’Sullivan S. Cannabidiol improves vasorelaxation in Zucker Diabetic Fatty rats through cyclooxygenase activation. J Pharmacol Exp Ther. 2014;351(2):457–66.
PubMed
Google Scholar
Wheal A, Jadoon K, Randall M, O'Sullivan S. In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker Diabetic Fatty rats. Front Pharmacol. 2017;8:248.
PubMed
PubMed Central
Google Scholar
Wiley J, Burston J, Leggett D, et al. CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol. 2005;145(3):293–300.
CAS
PubMed
PubMed Central
Google Scholar
Wiley J, Martin B. Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol. 2003;471(3):185–93.
CAS
PubMed
Google Scholar
Williams C, Kirkham T. Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors. Psychopharmacology. 1999;143(3):315–7.
CAS
PubMed
Google Scholar
Williams C, Kirkham T. Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav. 2002;71(1-2):333–40.
CAS
PubMed
Google Scholar
World Anti-Doping Agency. Summary of Major Modifications and Explanatory Notes. 2018. https://www.wada-ama.org/sites/default/files/prohibited_list_2018_summary_of_modifications_en.pdf. Accessed 31 Jan 2020.
World Anti-Doping Agency. Detection limits for the confirmatory quantification of threshold substances. 2019.
Google Scholar
World Health Organization. 2019. https://www.who.int/medicines/access/controlled-substances/UNSG_letter_ECDD41_recommendations_cannabis_24Jan19.pdf?ua=1. Accessed 31 Jan 2020.
Wray L, Stott C, Jones N, Wright S. Cannabidiol does not convert to Δ(9)-tetrahydrocannabinol in an in vivo animal model. Cannabis Cannabinoid Res. 2017;2(1):282–7.
CAS
PubMed
PubMed Central
Google Scholar
Xiong Y, Mahmood A, Chopp M. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chin J Traumatol. 2018;21(3):137–51.
PubMed
PubMed Central
Google Scholar
Yi P, Hsiao Y, Tsai C, Jan T, Lu C, Chang F. Serotonergic system in the central nucleus of amygdala mediates cannabidiol-induced sleep alteration. Open Sleep J. 2008;1:58–68.
Google Scholar
Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018;19(3):833.
PubMed Central
Google Scholar
Zuardi A. Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr. 2008;30(3):271–80.
PubMed
Google Scholar
Zuardi A, Cosme R, Graeff F, Guimaraes F. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol. 1993;7(1S):82–8.
CAS
PubMed
Google Scholar
Zuardi A, Rodrigues N, Silva A, et al. Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Front Pharmacol. 2017;8.